For someone at 200 pounds, roughly 20 to 36 pounds
Its also important to note that for patients using Wegovy to reduce heart attack and stroke risk, which Australias Therapeutic Goods Administration recently approved it for, theres no evidence that cardiovascular benefits will be achieved at lower-than-recommended doses
These findings, along with additional research , have found that people taking higher dosages of tirzepatide and people without type 2 diabetes tend to lose more weight than those on lower dosages and without the condition
Pre-surgical preparation Regular health assessments Nutritional guidance Physical activity recommendations Psychological support 3
Tirzepatide, with a molecular weight exceeding 4,800 daltons, is structurally and chemically distinct from these substances and would not trigger a positive result on these panels